|
Temozolomide (TMZ) Clinical Trials
11 actively recruiting trials across 5 locations
Also known as: TMZ, Temodal, Temodar
Pipeline
Phase 1: 1Phase 2: 5Phase 1/2: 5
Top Sponsors
- University of Birmingham1
- Theodore Laetsch1
- Sun Yat-sen University1
- Nationwide Children's Hospital1
- Medical University of Vienna1
Indications
- Cancer11
- Glioblastoma Multiforme (GBM)2
- Relapsed Neuroblastoma2
- Glioblastoma Multiforme2
- Glioma2
Other6 trials
Springdale, Arkansas1 trial
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Highlands Oncology Group
Phase 2
La Jolla, California1 trial
Aurora, Colorado1 trial
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Children's Hospital Colorado
Phase 2
Chicago, Illinois1 trial
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Ann & Robert H. Lurie Children's Hospital of Chicago
Phase 2
Philadelphia, Pennsylvania1 trial
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Children's Hospital of Philadelphia
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.